MannKind Appoints Christine Mundkur to its Board of Directors
November 27, 2018 at 09:00 am EST
MannKind Corporation announced that Christine Mundkur has joined its Board of Directors, effective November 27, 2018. Ms. Mundkur will also serve as a member of the Audit Committee of the Board. Ms. Mundkur brings 25 years of experience in the pharmaceutical industry to the MannKind Board. Ms. Mundkur most recently served as chief executive officer and the non-voting chairman of the board of directors for Impopharma Inc.